Login / Signup

Adequate information about clinical trial results must be given to participants.

Rafael Dal-RéArthur L CaplanSøren HolmReecha SofatRichard Stephens
Published in: Nature medicine (2024)
Keyphrases
  • clinical trial
  • phase ii
  • health information
  • open label
  • double blind
  • study protocol
  • phase iii
  • healthcare